Hormones of thyroid gland in sera of rats treated with different dose of concentrated potassium iodine solutions

Introduction Potassium iodine (KI) is used as a drug therapy for treating numerous diseases such as small-vessel vasculitis, erythema nodosum, vasculitis nodularis, Sweet's syndrome, tuberculosis and granulomatosis, and for iodized salt. At the same time, KI can be harmful. Iodine intake may in...

Full description

Bibliographic Details
Main Authors: Marković Ljiljana, Mihailović-Vučinić Violeta, Aritonović Jelena
Format: Article
Language:English
Published: Serbian Medical Society 2010-01-01
Series:Srpski Arhiv za Celokupno Lekarstvo
Subjects:
KI
T3
T4
TSH
Online Access:http://www.doiserbia.nb.rs/img/doi/0370-8179/2010/0370-81791006323M.pdf
id doaj-141ce5d0300748b0baf56c52ae5a3346
record_format Article
spelling doaj-141ce5d0300748b0baf56c52ae5a33462021-01-02T05:30:05ZengSerbian Medical SocietySrpski Arhiv za Celokupno Lekarstvo0370-81792010-01-011385-632332710.2298/SARH1006323MHormones of thyroid gland in sera of rats treated with different dose of concentrated potassium iodine solutionsMarković LjiljanaMihailović-Vučinić VioletaAritonović JelenaIntroduction Potassium iodine (KI) is used as a drug therapy for treating numerous diseases such as small-vessel vasculitis, erythema nodosum, vasculitis nodularis, Sweet's syndrome, tuberculosis and granulomatosis, and for iodized salt. At the same time, KI can be harmful. Iodine intake may increase the frequency of thyroiditis in humans, and may induce the occurrence of experimental thyroiditis (ET) in animals. Investigations on an experimental model for the examination of thyroiditis in Wistar rats have clearly showed morphological changes in the rat thyroid evoked by KI administration. Objective The purpose of this study was to compare the effects of low and high doses of KI on the thyroid gland of Wistar rats and determine the effect on hormone status (T4, T3 and TSH) in this rat strain. Methods Two groups of rats from the Wistar strain were treated with a low iodine dose (225 μg/g BW) and with a high iodine dose (675 μg/g BW) of KI solutions. Untreated nonimmunized animals served as controls. The solution was administrated daily intraperitoneally during the period of 26 consecutive days. Results Monitoring hormone status (TSH, T3 and T4) and morphological changes it was found that therapeutic doses of KI applied in treatment induced the occurrence of experimental thyroiditis (chronic destructive Hashimoto's thyroiditis in humans) and cell necrosis in animals not carrying a genetic susceptibility. Significant inflammatory changes were observed in rats treated with a high iodine dose. Conclusion The early iodine induced cell necrosis and inflammation in the nonimmunized animals without genetic susceptibility is a new experimental model of thyroiditis. . http://www.doiserbia.nb.rs/img/doi/0370-8179/2010/0370-81791006323M.pdfexperimental thyroiditisKIT3T4TSHrats
collection DOAJ
language English
format Article
sources DOAJ
author Marković Ljiljana
Mihailović-Vučinić Violeta
Aritonović Jelena
spellingShingle Marković Ljiljana
Mihailović-Vučinić Violeta
Aritonović Jelena
Hormones of thyroid gland in sera of rats treated with different dose of concentrated potassium iodine solutions
Srpski Arhiv za Celokupno Lekarstvo
experimental thyroiditis
KI
T3
T4
TSH
rats
author_facet Marković Ljiljana
Mihailović-Vučinić Violeta
Aritonović Jelena
author_sort Marković Ljiljana
title Hormones of thyroid gland in sera of rats treated with different dose of concentrated potassium iodine solutions
title_short Hormones of thyroid gland in sera of rats treated with different dose of concentrated potassium iodine solutions
title_full Hormones of thyroid gland in sera of rats treated with different dose of concentrated potassium iodine solutions
title_fullStr Hormones of thyroid gland in sera of rats treated with different dose of concentrated potassium iodine solutions
title_full_unstemmed Hormones of thyroid gland in sera of rats treated with different dose of concentrated potassium iodine solutions
title_sort hormones of thyroid gland in sera of rats treated with different dose of concentrated potassium iodine solutions
publisher Serbian Medical Society
series Srpski Arhiv za Celokupno Lekarstvo
issn 0370-8179
publishDate 2010-01-01
description Introduction Potassium iodine (KI) is used as a drug therapy for treating numerous diseases such as small-vessel vasculitis, erythema nodosum, vasculitis nodularis, Sweet's syndrome, tuberculosis and granulomatosis, and for iodized salt. At the same time, KI can be harmful. Iodine intake may increase the frequency of thyroiditis in humans, and may induce the occurrence of experimental thyroiditis (ET) in animals. Investigations on an experimental model for the examination of thyroiditis in Wistar rats have clearly showed morphological changes in the rat thyroid evoked by KI administration. Objective The purpose of this study was to compare the effects of low and high doses of KI on the thyroid gland of Wistar rats and determine the effect on hormone status (T4, T3 and TSH) in this rat strain. Methods Two groups of rats from the Wistar strain were treated with a low iodine dose (225 μg/g BW) and with a high iodine dose (675 μg/g BW) of KI solutions. Untreated nonimmunized animals served as controls. The solution was administrated daily intraperitoneally during the period of 26 consecutive days. Results Monitoring hormone status (TSH, T3 and T4) and morphological changes it was found that therapeutic doses of KI applied in treatment induced the occurrence of experimental thyroiditis (chronic destructive Hashimoto's thyroiditis in humans) and cell necrosis in animals not carrying a genetic susceptibility. Significant inflammatory changes were observed in rats treated with a high iodine dose. Conclusion The early iodine induced cell necrosis and inflammation in the nonimmunized animals without genetic susceptibility is a new experimental model of thyroiditis. .
topic experimental thyroiditis
KI
T3
T4
TSH
rats
url http://www.doiserbia.nb.rs/img/doi/0370-8179/2010/0370-81791006323M.pdf
work_keys_str_mv AT markovicljiljana hormonesofthyroidglandinseraofratstreatedwithdifferentdoseofconcentratedpotassiumiodinesolutions
AT mihailovicvucinicvioleta hormonesofthyroidglandinseraofratstreatedwithdifferentdoseofconcentratedpotassiumiodinesolutions
AT aritonovicjelena hormonesofthyroidglandinseraofratstreatedwithdifferentdoseofconcentratedpotassiumiodinesolutions
_version_ 1724358848782794752